-transparent.png){kind=logo}
Renografin 76 has been shown to have significant calcium-binding properties in vivo and in vitro. Two contrast media solutions were compared by selective injection into the right coronary artery of dogs. One set of injections was made with commercially available Renografin 76 (referred to as stock Renografin) and another set of injections was made with Renografin 76 to which had been added 24 mMols/liter of calcium chloride dihydrate. Ventricular fibrillation occurred significantly more often with the stock Renografin 76. The nature of the calcium binding and its effects are discussed.
Related Publications
K R Thomson, and
M R Violante, and
T Kenyon, and
H W Fischer
July 1984,
Radiology,
K R Thomson, and
M R Violante, and
T Kenyon, and
H W Fischer
January 1988,
Catheterization and cardiovascular diagnosis,
K R Thomson, and
M R Violante, and
T Kenyon, and
H W Fischer
May 1976,
American heart journal,
K R Thomson, and
M R Violante, and
T Kenyon, and
H W Fischer
June 1983,
Journal of the American College of Cardiology,
K R Thomson, and
M R Violante, and
T Kenyon, and
H W Fischer
May 1981,
AJR. American journal of roentgenology,
K R Thomson, and
M R Violante, and
T Kenyon, and
H W Fischer
September 1977,
Radiology,
K R Thomson, and
M R Violante, and
T Kenyon, and
H W Fischer
January 1984,
Investigative radiology,
K R Thomson, and
M R Violante, and
T Kenyon, and
H W Fischer
September 1974,
Radiology,
K R Thomson, and
M R Violante, and
T Kenyon, and
H W Fischer
March 1981,
The American journal of cardiology,
K R Thomson, and
M R Violante, and
T Kenyon, and
H W Fischer
August 1971,
Radiology,
